PharmaVoice 4. Juni 2026 Pharma is betting big on PD-1/VEGF bispecifics. But are companies chasing the wrong target?
FierceBiotech 4. Juni 2026 From business strategy to CAR-T responses, for Cabaletta it’s all about ‘durability’
Bruker 4. Juni 2026 Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026 - 巴士的報
Eli Lilly 4. Juni 2026 Eli Lilly continues genetic medicine push with $1.9bn Ascidian partnership - Pharmaceutical Technology
Eli Lilly 4. Juni 2026 Eli Lilly forms billion-dollar genetic kidney disease partnership with US biotech Ascidian Therapeutics - medwatch.com
FierceBiotech 4. Juni 2026 Alnylam pens $2B deal with Inceptive to transform siRNA design with AI pioneer
Samsung Biologics 4. Juni 2026 Global firms tighten hold on Korea’s biopharma supply chain - KED Global
Lonza News 4. Juni 2026 Lonza advances integrated DNA‑to‑IND programmes with acceleration, derisking and innovation - Manufacturing Chemist